Mesoblast (MEOBF) Receivables (2015 - 2026)

Mesoblast has disclosed Receivables across 12 years of filings, most recently posting $57.7 million for Q2 2026.

• In Q2 2026, Receivables rose 282.98% year-over-year to $57.7 million; the TTM figure through Jun 2026 stood at $57.7 million (up 282.98% YoY), while the FY2026 annual figure was $57.7 million, up 180.32% from the prior year.
• Receivables came in at $57.7 million for Q2 2026 at Mesoblast, down from $71.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $71.3 million in Q4 2025 to a low of $3.9 million in Q3 2022.
• Average Receivables over 5 years is $18.0 million, with a median of $6.5 million recorded in 2023.
• The largest YoY upside for Receivables was 1077.31% in 2025 against a maximum downside of 45.7% in 2025.
• Over 5 years, Receivables stood at $5.1 million in 2022, then retreated by 21.84% to $4.0 million in 2023, then jumped by 51.55% to $6.1 million in 2024, then surged by 1077.31% to $71.3 million in 2025, then fell by 19.17% to $57.7 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $57.7 million in Q2 2026, $71.3 million in Q4 2025, and $15.1 million in Q2 2025.